A recent meta-analysis reported that the levels of interleukins (IL-6 and IL-1β) and tumor necrosis factor-alpha (TNF-α), were increased in the blood of patients with ALS compared with healthy control (HC), implicating a peripheral systemic pro-inflammatory response8. Here, IL6 is linked to amyotrophic lateral sclerosis.